{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:19:55Z","timestamp":1793067595024,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["BFF17-0008"],"award-info":[{"award-number":["BFF17-0008"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41593-025-02117-8","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:03:02Z","timestamp":1763978582000},"page":"25-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A myeloid trisomy 21-associated gene variant is protective from Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"29","author":[{"given":"Mengmeng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava V.","family":"Papetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Finkbeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2650-3082","authenticated-orcid":false,"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2117_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tins.2022.02.005","volume":"45","author":"SM Neuner","year":"2022","unstructured":"Neuner, S. M. et al. Translational approaches to understanding resilience to Alzheimer\u2019s disease. Trends Neurosci. 45, 369\u2013383 (2022).","journal-title":"Trends Neurosci."},{"key":"2117_CR2","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/alz.12899","volume":"19","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: an age-continuous perspective. Alzheimers Dement. 19, 2831\u20132841 (2023).","journal-title":"Alzheimers Dement."},{"key":"2117_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","volume":"6","author":"J Rahimi","year":"2014","unstructured":"Rahimi, J. & Kovacs, G. G. Prevalence of mixed pathologies in the aging brain. Alzheimers Res. Ther. 6, 82 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"2117_CR4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-023-02397-2","volume":"29","author":"H Bouzid","year":"2023","unstructured":"Bouzid, H. et al. Clonal hematopoiesis is associated with protection from Alzheimer\u2019s disease. Nat. Med. 29, 1662\u20131670 (2023).","journal-title":"Nat. Med."},{"key":"2117_CR5","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.immuni.2023.11.011","volume":"56","author":"CM Wilk","year":"2023","unstructured":"Wilk, C. M. et al. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders. Immunity 56, 2790\u20132802 (2023).","journal-title":"Immunity"},{"key":"2117_CR6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","volume":"16","author":"FK Wiseman","year":"2015","unstructured":"Wiseman, F. K. et al. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat. Rev. Neurosci. 16, 564\u2013574 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"2117_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott, I. T. & Head, E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat. Rev. Neurol. 15, 135\u2013147 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"2117_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","volume":"13","author":"DM Mann","year":"1988","unstructured":"Mann, D. M. Alzheimer\u2019s disease and Down\u2019s syndrome. Histopathology 13, 125\u2013137 (1988).","journal-title":"Histopathology"},{"key":"2117_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere, C. A. et al. Sequence of deposition of heterogeneous amyloid \u03b2-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3, 16\u201332 (1996).","journal-title":"Neurobiol. Dis."},{"key":"2117_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/exnr.1997.6777","volume":"150","author":"JB Leverenz","year":"1998","unstructured":"Leverenz, J. B. & Raskind, M. A. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp. Neurol. 150, 296\u2013304 (1998).","journal-title":"Exp. Neurol."},{"key":"2117_CR11","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.neuron.2022.04.001","volume":"110","author":"AC Martini","year":"2022","unstructured":"Martini, A. C., Gross, T. J., Head, E. & Mapstone, M. Beyond amyloid: immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome. Neuron 110, 2063\u20132079 (2022).","journal-title":"Neuron"},{"key":"2117_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1352\/2008.46:215-228","volume":"46","author":"SJ Krinsky-McHale","year":"2008","unstructured":"Krinsky-McHale, S. J. et al. Successful aging in a 70-year-old man with down syndrome: a case study. Intellect. Dev. Disabil. 46, 215\u2013228 (2008).","journal-title":"Intellect. Dev. Disabil."},{"key":"2117_CR13","doi-asserted-by":"crossref","first-page":"749480","DOI":"10.3389\/fgene.2021.749480","volume":"12","author":"MP Osuna-Marco","year":"2021","unstructured":"Osuna-Marco, M. P., L\u00f3pez-Barahona, M., L\u00f3pez-Ibor, B. & Tejera, \u00c1. M. Ten reasons why people with Down syndrome are protected from the development of most solid tumors\u2014a review. Front. Genet. 12, 749480 (2021).","journal-title":"Front. Genet."},{"key":"2117_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","volume":"5","author":"JK Hitzler","year":"2005","unstructured":"Hitzler, J. K. & Zipursky, A. Origins of leukaemia in children with Down syndrome. Nat. Rev. Cancer 5, 11\u201320 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"2117_CR15","first-page":"76","volume":"4","author":"MK Mateos","year":"2015","unstructured":"Mateos, M. K., Barbaric, D., Byatt, S.-A., Sutton, R. & Marshall, G. M. Down syndrome and leukemia: insights into leukemogenesis and translational targets. Transl. Pediatr. 4, 76\u201392 (2015).","journal-title":"Transl. Pediatr."},{"key":"2117_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle, H., Clemmensen, I. H. & Mikkelsen, M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet 355, 165\u2013169 (2000).","journal-title":"Lancet"},{"key":"2117_CR17","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts, I. et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood 122, 3908\u20133917 (2013).","journal-title":"Blood"},{"key":"2117_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler, J. et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32, 148\u2013152 (2002).","journal-title":"Nat. Genet."},{"key":"2117_CR19","volume":"5","author":"SI Nikolaev","year":"2014","unstructured":"Nikolaev, S. I. et al. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nat. Commun. 5, 4654 (2014).","journal-title":"Nat. Commun."},{"key":"2117_CR20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida, K. et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat. Genet. 45, 1293\u20131299 (2013).","journal-title":"Nat. Genet."},{"key":"2117_CR21","doi-asserted-by":"crossref","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"2117_CR22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen, D. V., Hanson, J. E. & Sheng, M. Microglia in Alzheimer\u2019s disease. J. Cell Biol. 217, 459\u2013472 (2018).","journal-title":"J. Cell Biol."},{"key":"2117_CR23","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1172\/JCI90604","volume":"127","author":"IR Holtman","year":"2017","unstructured":"Holtman, I. R., Skola, D. & Glass, C. K. Transcriptional control of microglia phenotypes in health and disease. J. Clin. Invest. 127, 3220\u20133229 (2017).","journal-title":"J. Clin. Invest."},{"key":"2117_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.06.007","volume":"36","author":"M Labuhn","year":"2019","unstructured":"Labuhn, M. et al. Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome. Cancer Cell 36, 123\u2013138 (2019).","journal-title":"Cancer Cell"},{"key":"2117_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cyto.2015.02.005","volume":"74","author":"SE Broughton","year":"2015","unstructured":"Broughton, S. E. et al. The \u03b2c receptor family\u2014structural insights and their functional implications. Cytokine 74, 247\u2013258 (2015).","journal-title":"Cytokine"},{"key":"2117_CR26","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1016\/j.celrep.2020.02.028","volume":"30","author":"V Chitu","year":"2020","unstructured":"Chitu, V. et al. Microglial homeostasis requires balanced CSF-1\/CSF-2 receptor signaling. Cell Rep. 30, 3004\u20133019 (2020).","journal-title":"Cell Rep."},{"key":"2117_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2010-091471","volume":"21","author":"TD Boyd","year":"2010","unstructured":"Boyd, T. D. et al. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J. Alzheimers Dis. 21, 507\u2013518 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"2117_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1471-4906(02)02260-3","volume":"23","author":"JA Hamilton","year":"2002","unstructured":"Hamilton, J. A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403\u2013408 (2002).","journal-title":"Trends Immunol."},{"key":"2117_CR29","doi-asserted-by":"crossref","first-page":"e0168106","DOI":"10.1371\/journal.pone.0168106","volume":"11","author":"L-T Kao","year":"2016","unstructured":"Kao, L.-T. et al. Rheumatoid arthritis was negatively associated with Alzheimer\u2019s disease: a population-based case-control study. PLoS ONE 11, e0168106 (2016).","journal-title":"PLoS ONE"},{"key":"2117_CR30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10787-023-01397-5","volume":"32","author":"G-S Li","year":"2024","unstructured":"Li, G.-S. et al. Rheumatoid arthritis is a protective factor against Alzheimer\u2019s disease: a bidirectional two-sample Mendelian randomization study. Inflammopharmacology 32, 863\u2013871 (2024).","journal-title":"Inflammopharmacology"},{"key":"2117_CR31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","volume":"319","author":"T Kiyota","year":"2018","unstructured":"Kiyota, T. et al. Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer\u2019s disease mice. J. Neuroimmunol. 319, 80\u201392 (2018).","journal-title":"J. Neuroimmunol."},{"key":"2117_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105694","volume":"168","author":"MM Ahmed","year":"2022","unstructured":"Ahmed, M. M. et al. The innate immune system stimulating cytokine GM-CSF improves learning\/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning\/memory in wild-type mice. Neurobiol. Dis. 168, 105694 (2022).","journal-title":"Neurobiol. Dis."},{"key":"2117_CR33","volume":"7","author":"H Potter","year":"2021","unstructured":"Potter, H. et al. Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer\u2019s disease. Alzheimers Dement. 7, e12158 (2021).","journal-title":"Alzheimers Dement."},{"key":"2117_CR34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu, S. et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science 381, 1176\u20131182 (2023).","journal-title":"Science"},{"key":"2117_CR35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","volume":"4","author":"C Geula","year":"1998","unstructured":"Geula, C. et al. Aging renders the brain vulnerable to amyloid \u03b2-protein neurotoxicity. Nat. Med. 4, 827\u2013831 (1998).","journal-title":"Nat. Med."},{"key":"2117_CR36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin, M. et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell Stem Cell 29, 1135\u20131153 (2022).","journal-title":"Cell Stem Cell"},{"key":"2117_CR37","volume":"12","author":"AC Martini","year":"2020","unstructured":"Martini, A. C. et al. Distribution of microglial phenotypes as a function of age and Alzheimer\u2019s disease neuropathology in the brains of people with Down syndrome. Alzheimers Dement. 12, e12113 (2020).","journal-title":"Alzheimers Dement."},{"key":"2117_CR38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove, H. et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22, 1021\u20131035 (2019).","journal-title":"Nat. Neurosci."},{"key":"2117_CR39","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell 186, 4386\u20134403 (2023).","journal-title":"Cell"},{"key":"2117_CR40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li, J.-Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503 (2008).","journal-title":"Nat. Med."},{"key":"2117_CR41","doi-asserted-by":"crossref","first-page":"15209","DOI":"10.1073\/pnas.2001305117","volume":"117","author":"DB Hoban","year":"2020","unstructured":"Hoban, D. B. et al. Impact of \u03b1-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized \u03b1-synuclein rat model of PD. Proc. Natl Acad. Sci. USA 117, 15209\u201315220 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2117_CR42","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","volume":"113","author":"W Li","year":"2016","unstructured":"Li, W. et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc. Natl Acad. Sci. USA 113, 6544\u20136549 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2117_CR43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature22067","volume":"544","author":"JM Castellano","year":"2017","unstructured":"Castellano, J. M. et al. Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 544, 488\u2013492 (2017).","journal-title":"Nature"},{"key":"2117_CR44","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2117_CR45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma, D. P. et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126, 9\u201316 (2015).","journal-title":"Blood"},{"key":"2117_CR46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41587-023-01798-5","volume":"42","author":"R Vieira","year":"2024","unstructured":"Vieira, R. et al. Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain. Nat. Biotechnol. 42, 719\u2013730 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2117_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112956","volume":"42","author":"P Mishra","year":"2023","unstructured":"Mishra, P. et al. Rescue of Alzheimer\u2019s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells. Cell Rep. 42, 112956 (2023).","journal-title":"Cell Rep."},{"key":"2117_CR48","volume":"32","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Efficient strategies for microglia replacement in the central nervous system. Cell Rep. 32, 108041 (2020).","journal-title":"Cell Rep."},{"key":"2117_CR49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.stem.2023.07.006","volume":"30","author":"Y Yoo","year":"2023","unstructured":"Yoo, Y., Neumayer, G., Shibuya, Y., Marc-Daniel Mader, M. & Wernig, M. A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer\u2019s disease. Cell Stem Cell 30, 1043\u20131053 (2023).","journal-title":"Cell Stem Cell"},{"key":"2117_CR50","doi-asserted-by":"crossref","first-page":"e20220857","DOI":"10.1084\/jem.20220857","volume":"220","author":"JP Chadarevian","year":"2023","unstructured":"Chadarevian, J. P. et al. Engineering an inhibitor-resistant human CSF1R variant for microglia replacement. J. Exp. Med. 220, e20220857 (2023).","journal-title":"J. Exp. Med."},{"key":"2117_CR51","doi-asserted-by":"crossref","first-page":"e14479","DOI":"10.1002\/alz.14479","volume":"21","author":"J-J Liou","year":"2025","unstructured":"Liou, J-J. et al. A neuropathology case report of a woman with Down syndrome who remained cognitively stable: implications for resilience to neuropathology. Alzheimers Dement. 21, e14479 (2025).","journal-title":"Alzheimers Dement."},{"key":"2117_CR52","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.neuron.2025.03.036","volume":"113","author":"AV Papetti","year":"2025","unstructured":"Papetti, A. V., Jin, M., Ma, Z., Stillitano, A. C. & Jiang, P. Chimeric brain models: unlocking insights into human neural development, aging, diseases, and cell therapies. Neuron 113, 2230\u20132250 (2025).","journal-title":"Neuron"},{"key":"2117_CR53","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111\u20132116 (2019).","journal-title":"Nat. Neurosci."},{"key":"2117_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade, A. et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat. Commun. 11, 5370 (2020).","journal-title":"Nat. Commun."},{"key":"2117_CR55","doi-asserted-by":"publisher","unstructured":"Jin, M. et al. Co-transplantation-based human-mouse chimeric brain models to study human glial-glial and glial-neuronal interactions. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.03.601990 (2024).","DOI":"10.1101\/2024.07.03.601990"},{"key":"2117_CR56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343\u2013345 (2009).","journal-title":"Nat. Methods"},{"key":"2117_CR57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.omtn.2017.06.007","volume":"8","author":"S Li","year":"2017","unstructured":"Li, S., Zhang, A., Xue, H., Li, D. & Liu, Y. One-step piggyBac transposon-based CRISPR\/Cas9 activation of multiple genes. Mol. Ther. Nucleic Acids 8, 64\u201376 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2117_CR58","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"2117_CR59","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"2117_CR60","doi-asserted-by":"crossref","first-page":"101208","DOI":"10.1016\/j.omtm.2024.101208","volume":"32","author":"M Pille","year":"2024","unstructured":"Pille, M. et al. Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Mol. Ther. Methods Clin. Dev. 32, 101208 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2117_CR61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","volume":"649","author":"DY Guschin","year":"2010","unstructured":"Guschin, D. Y. et al. A rapid and general assay for monitoring endogenous gene modification. Methods Mol. Biol. 649, 247\u2013256 (2010).","journal-title":"Methods Mol. Biol."},{"key":"2117_CR62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/7651_2014_73","volume":"1307","author":"H Xue","year":"2016","unstructured":"Xue, H., Wu, J., Rao, M. S. & Liu, Y. Genetic modification in human pluripotent stem cells by homologous recombination and CRISPR\/Cas9 system. Methods Mol. Biol. 1307, 173\u2013190 (2016).","journal-title":"Methods Mol. Biol."},{"key":"2117_CR63","first-page":"e52539","volume":"99","author":"S Li","year":"2015","unstructured":"Li, S. et al. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR\/Cas9 and Cas9 double nickase system. J. Vis. Exp. 99, e52539 (2015).","journal-title":"J. Vis. Exp."},{"key":"2117_CR64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/scd.2011.0163","volume":"21","author":"CC Macarthur","year":"2012","unstructured":"Macarthur, C. C. et al. Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev. 21, 191\u2013205 (2012).","journal-title":"Stem Cells Dev."},{"key":"2117_CR65","volume":"5","author":"C Chen","year":"2014","unstructured":"Chen, C. et al. Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun. 5, 4430 (2014).","journal-title":"Nat. Commun."},{"key":"2117_CR66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","volume":"24","author":"R Xu","year":"2019","unstructured":"Xu, R. et al. OLIG2 drives abnormal neurodevelopmental phenotypes in human iPSC-based organoid and chimeric mouse models of Down syndrome. Cell Stem Cell 24, 908\u2013926 (2019).","journal-title":"Cell Stem Cell"},{"key":"2117_CR67","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.stemcr.2017.05.017","volume":"8","author":"W Haenseler","year":"2017","unstructured":"Haenseler, W. et al. A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Rep. 8, 1727\u20131742 (2017).","journal-title":"Stem Cell Rep."},{"key":"2117_CR68","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.stemcr.2022.09.012","volume":"17","author":"M Jin","year":"2022","unstructured":"Jin, M., Alam, M. M., Liu, A. Y.-C. & Jiang, P. Rag2\u2212\/\u2212 accelerates lipofuscin accumulation in the brain: implications for human stem cell brain transplantation studies. Stem Cell Reports 17, 2381\u20132391 (2022).","journal-title":"Stem Cell Reports"},{"key":"2117_CR69","doi-asserted-by":"crossref","first-page":"101847","DOI":"10.1016\/j.xpro.2022.101847","volume":"3","author":"M Jin","year":"2022","unstructured":"Jin, M., Ma, Z. & Jiang, P. Generation of iPSC-based human-mouse microglial brain chimeras to study senescence of human microglia. STAR Protoc. 3, 101847 (2022).","journal-title":"STAR Protoc."},{"key":"2117_CR70","volume":"11","author":"R Xu","year":"2020","unstructured":"Xu, R. et al. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat. Commun. 11, 1577 (2020).","journal-title":"Nat. Commun."},{"key":"2117_CR71","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-016-1630-5","volume":"132","author":"E Sanchez-Mejias","year":"2016","unstructured":"Sanchez-Mejias, E. et al. Soluble phospho-tau from Alzheimer\u2019s disease hippocampus drives microglial degeneration. Acta Neuropathol. 132, 897\u2013916 (2016).","journal-title":"Acta Neuropathol."},{"key":"2117_CR72","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba, M. et al. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J. Neurosci. 33, 1024\u20131037 (2013).","journal-title":"J. Neurosci."},{"key":"2117_CR73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","volume":"73","author":"E Peeraer","year":"2015","unstructured":"Peeraer, E. et al. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol. Dis. 73, 83\u201395 (2015).","journal-title":"Neurobiol. Dis."},{"key":"2117_CR74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda, S. et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol. 129, 221\u2013237 (2015).","journal-title":"Acta Neuropathol."},{"key":"2117_CR75","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.3390\/ijms22158042","volume":"22","author":"M Jin","year":"2021","unstructured":"Jin, M. et al. Interleukin-17 and Th17 Lymphocytes directly impair motoneuron survival of wildtype and FUS-ALS mutant human iPSCs. Int. J. Mol. Sci. 22, 8042 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2117_CR76","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1093\/brain\/awaa326","volume":"143","author":"L Flores-Aguilar","year":"2020","unstructured":"Flores-Aguilar, L. et al. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome. Brain 143, 3653\u20133671 (2020).","journal-title":"Brain"},{"key":"2117_CR77","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/bioinformatics\/btw413","volume":"32","author":"D Legland","year":"2016","unstructured":"Legland, D., Arganda-Carreras, I. & Andrey, P. MorphoLibJ: integrated library and plugins for mathematical morphology with ImageJ. Bioinformatics 32, 3532\u20133534 (2016).","journal-title":"Bioinformatics"},{"key":"2117_CR78","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/0008-5472.CAN-20-3562","volume":"81","author":"SA Miller","year":"2021","unstructured":"Miller, S. A. et al. LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF-mutant colorectal cancer. Cancer Res. 81, 3791\u20133805 (2021).","journal-title":"Cancer Res."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02117-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:33:08Z","timestamp":1767796388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02117-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02117-8","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.J. and M.J. have filed a patent related to this work (US patent application no. 63\/563,637). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}